RNA, U6 small nuclear 920, pseudogene (RNU6-920P)

RNA, U6 small nuclear 920, pseudogene (RNU6-920P) is a processed pseudogene in the human genome[1][3][7]. It is derived from the U6 small nuclear RNA (snRNA) gene, which plays an essential role in the spliceosome machinery for pre-mRNA splicing. However, as a pseudogene, RNU6-920P does not produce a functional snRNA[1][3][7]. Processed pseudogenes typically arise via retrotransposition events, resulting in gene copies that lack introns and regulatory elements and are generally considered non-functional[4]. There is no evidence that RNU6-920P serves as a functional biological target, therapeutic target, or biomarker. While some pseudogenes are known to transcribe regulatory RNAs or act as miRNA sponges, no such functionality has been attributed to RNU6-920P itself[2]. There are no known disease associations or clinical utility for this pseudogene. Key points: - RNU6-920P is not a therapeutic target and is not linked to any established drug interactions. - It is classified as a processed pseudogene, not an active gene, enzyme, receptor, or molecular target for therapy. - There is no evidence of direct biological function, disease association, or relevance as a biomarker for RNU6-920P specifically. - The nomenclature and molecular identity are accurate; it is a properly described human pseudogene[1][3][5][7].

Other names

RNA, U6 small nuclear 920, pseudogeneRNU6-920P

Not applicable (no known drug interactions)